Response to the Letter Regarding "Intratympanic Administration of Edaravone for Sudden Sensorineural Hearing Loss: A Prospective Case Series with Historical Controls"
Main Article Content
Abstract
Cite this article as: Nitta Y. Response to the letter regarding "intratympanic administration of edaravone for sudden sensorineural hearing loss: A prospective case series with historical controls". J Int Adv Otol. 2025, 21, 0492, doi: 10.5152/iao.2025.2520492.